iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Rossari Biotech slips after Q2 PAT declines 8% YoY; EBITDA margin remains stable

7 Nov 2022 , 05:26 PM

The company had reported a net profit of Rs 26.23 crore in Q2 FY22. Revenue from operations increased by 10.6% to Rs 425.44 crore in Q2 FY23 versus Rs 384.52 crore in Q2 FY22. Total Expense increased by 11.9% to Rs 392.75 crore in Q2 FY23 from Rs 351.11 crore in Q2 FY22, due to higher cost of material (up 15.4% YoY), higher other expenses (up 72.5% YoY) and higher employee expenses (up 72.9% YoY). EBITDA fell by 1.9% YoY to Rs 56.6 crore in Q2 FY23 from Rs 57.7 crore in same quarter last fiscal. EBITDA margin remained stable at 13.3%. Profit before tax fell by 6.1% to Rs 33.62 crore in Q2 FY23 as compared to Rs 35.81 crore in Q2 FY22. Commenting on the performance, in a joint statement, Edward Menezes, promoter & executive chairman, and Sunil Chari, promoter & managing director, said: ?We have reported a steady performance in our key business segments during the quarter amidst a volatile operating environment. On the raw material front we are now witnessing some price stability. This should help maintain our margins through the second half of the year. During the quarter, we successfully acquired an additional 15% stake in Unitop and 8% in Tristar, taking our total holding to 80% and 84% respectively. Since the acquisition, both companies have added tremendous value to Rossari, and we are very pleased with the acquisitions and the seamless integration executed by our team. To maintain our market position as a top provider of intelligent and sustainable solutions, our long-term focus will continue to be on growing our wallet share among our current client base while expanding out to emerging customer segments.? Rossari Biotech is a speciality-chemicals manufacturer providing intelligent and sustainable solutions for customers across industries. The company offers tailor-made solutions for home, personal care and performance chemicals (HPPC), textile speciality chemicals and animal health and nutrition (AHN). Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.